HC Wainwright & Co. Reiterates Buy on Precision BioSciences
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Precision BioSciences (NASDAQ:DTIL).
August 07, 2023 | 6:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Precision BioSciences' stock rating has been reiterated as 'Buy' by HC Wainwright & Co.
Analyst ratings often influence investor sentiment. A 'Buy' rating suggests that the analyst believes the stock will perform well in the future, which could lead to increased investor interest and a potential rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100